| |
Arthritis News Archive12-Jun-2008
(AFX UK Focus) 2008-06-11 12:50 Schering-Plough: Golimumab Phase III show improved rheumatoid arthritis signs (Interactive Investor)
NEW YORK (Thomson Financial) - Schering-Plough Corp. Wednesday said data from two Phase III trials of experimental rheumatoid arthritis drug golimumab showed that patients receiving subcutaneous golimumab injections every four weeks experienced significant improvements in the signs and symptoms of the disease as well as in physical function and disease activity.
Golimumab Eases Rheumatoid Arthritis Symptoms (HealthDay via Yahoo! News)
WEDNESDAY, June 11 (HealthDay News) -- Adding monthly injections of golimumab to weekly doses of methotrexate helped most people with rheumatoid arthritis, even putting some into remission, two new studies show.
Phase 3 Data Show Efficacy of Golimumab in Patients with Active Rheumatoid Arthritis Previously Treated with Anti-TNF ... (The San Francisco Examiner)
PARIS , June 11 /PRNewswire/ -- Findings presented for the first time from a novel, randomized, double-blind, placebo-controlled Phase 3 study showed that patients with moderately-to-severely active rheumatoid arthritis (RA) who were previously treated with anti-tumor necrosis factor (TNF)-alpha agents, experienced significant improvements in signs and symptoms and physical function after ...
Ardea Biosciences Presents Inflammation Program Data for Arthritis and Gout at 2008 Annual European Congress of ... (PR Newswire via Yahoo! Finance)
Ardea Biosciences, Inc. today announced that data will be presented on the Company's lead mitogen-activated ERK kinase inhibitor, RDEA119, demonstrating its potent activity in animal models of arthritis.
Golimumab Eases Rheumatoid Arthritis Symptoms (HealthCentral.com)
Copyright © 2008 ScoutNews LLC. All rights reserved. WEDNESDAY, June 11 (HealthDay News) -- Adding monthly injections of golimumab to weekly doses of methotrexate helped most people with rheumatoid arthritis, even putting some into remission, two new studies show.
High prevalence of periodontal disease in rheumatoid arthritis found (News-Medical-Net)
Over 1.3 million Americans suffer from rheumatoid arthritis (RA), a chronic, inflammatory disease of the joints. RA is a disabling condition, and can lead to long-term joint damage resulting in persistent pain and loss of function in affected areas. higher prevalence of periodontal disease in rheumatoid arthritis patients
Roche says its arthritis drug more effective (Reuters via Yahoo! News)
Roche Holding AG's MabThera was more effective in treating rheumatoid arthritis (RA) patients than other drugs with a more traditional mode of action, the Swiss drugmaker said on Wednesday.
Ofatumumab In Subcutaneous Study In Rheumatoid Arthritis Summary: Subcutaneous Administration Of Ofatumumab ... (Medical News Today)
Genmab A/S (OMX: GEN) announced a Phase I/II study to evaluate a subcutaneous route of administration of ofatumumab (HuMax-CD20(R)) in rheumatoid arthritis (RA) patients, stable on methotrexate will be initiated soon. The study, which will consist of two parts and include approximately 70 patients, will be conducted by GlaxoSmithKline.
J&J, Schering arthritis drug effective in trials (Reuters via Yahoo! News)
An experimental treatment for rheumatoid arthritis being developed by Johnson & Johnson and Schering-Plough Corp appeared to be effective and very safe in three late-stage trials, the companies said on Tuesday.
Back to Alternative Treatments for Arthritis
Back to Arthritis News Archive
|
|
|